GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (NAS:APYX) » Definitions » Shiller PE Ratio

Apyx Medical (Apyx Medical) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Apyx Medical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Apyx Medical Shiller PE Ratio Historical Data

The historical data trend for Apyx Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical Shiller PE Ratio Chart

Apyx Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Apyx Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Apyx Medical's Shiller PE Ratio

For the Medical Devices subindustry, Apyx Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apyx Medical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Apyx Medical's Shiller PE Ratio falls into.



Apyx Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Apyx Medical's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Apyx Medical's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.22/131.7762*131.7762
=-0.220

Current CPI (Mar. 2024) = 131.7762.

Apyx Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.070 100.560 -0.092
201409 -0.170 100.428 -0.223
201412 -0.390 99.070 -0.519
201503 0.570 99.621 0.754
201506 -0.060 100.684 -0.079
201509 -0.060 100.392 -0.079
201512 -0.050 99.792 -0.066
201603 -0.070 100.470 -0.092
201606 -0.020 101.688 -0.026
201609 -0.040 101.861 -0.052
201612 -0.040 101.863 -0.052
201703 -0.060 102.862 -0.077
201706 -0.040 103.349 -0.051
201709 -0.040 104.136 -0.051
201712 -0.030 104.011 -0.038
201803 -0.030 105.290 -0.038
201806 -0.010 106.317 -0.012
201809 1.960 106.507 2.425
201812 -0.120 105.998 -0.149
201903 -0.170 107.251 -0.209
201906 -0.130 108.070 -0.159
201909 -0.130 108.329 -0.158
201912 -0.160 108.420 -0.194
202003 -0.060 108.902 -0.073
202006 -0.140 108.767 -0.170
202009 -0.110 109.815 -0.132
202012 -0.040 109.897 -0.048
202103 -0.140 111.754 -0.165
202106 -0.120 114.631 -0.138
202109 -0.120 115.734 -0.137
202112 -0.060 117.630 -0.067
202203 -0.170 121.301 -0.185
202206 -0.160 125.017 -0.169
202209 -0.170 125.227 -0.179
202212 -0.170 125.222 -0.179
202303 -0.100 127.348 -0.103
202306 -0.030 128.729 -0.031
202309 -0.130 129.860 -0.132
202312 -0.280 129.419 -0.285
202403 -0.220 131.776 -0.220

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Apyx Medical  (NAS:APYX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Apyx Medical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Apyx Medical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Apyx Medical (Apyx Medical) Business Description

Traded in Other Exchanges
Address
5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Executives
Todd Hornsby officer: Executive Vice President 14321 HAWTHORNE DR., CARMEL IN 46033
Goodwin Charles D. Ii director, officer: Chief Executive Officer 5115 ULMERTON ROAD, CLEARWATER FL 33760
Wendy Lauren Levine director 75 KENMARE STREET, APT. 2D, NEW YORK NY 10012
Minnie Baylor-henry director C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803
Tara Semb officer: Chief Financial Officer 5516 RIVERSIDE HEIGHTS WAY, RICHMOND VA 23225
Craig A. Swandal director 5115 ULMERTON ROAD, CLEARWATER FL 33760
Michael Geraghty director 1342 CHERRY HILL ROAD, MENDOTA HEIGHTS MN 55118
Lawrence Waldman director 5115 ULMERTON RD., CLEARWATER FL 33770
John C. Andres director 86 CAPRI LANE, CHATHAM MA 02633
Jay D. Ewers officer: Chief Financial Officer 4 MANHATTANVILLE ROAD, SUITE 106, PURCHASE NY 10577
J Robert Saron director, officer: President
Robert Gershon director, officer: Chief Executive Officer 5115 ULMERTON ROAD, CLEARWATER FL 33760
Mccarthy John J. Iii officer: Chief CommercializationOfficer 23 RINALDO ROAD, NORTHPORT NY 11768
Scott Richard Davidson director C/O GREAT POINT PARTNERS, LLC, 165 MASON STREET, GREENWICH CT 06830
Moshe Citronowicz officer: Vice President of Operations